Personalis Inc (PSNL) Unusual Options Activity Today

Checking PSNL unusual options activity helps you spot when traders are making outsized bets on Personalis Inc before the broader market catches on. Personalis Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PSNL unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PSNL unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PSNL unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PSNL unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities.

The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.

Catalysts rarely arrive without a footprint, and PSNL unusual options activity is often where that footprint shows up first. Our scanner tracks Personalis Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PSNL unusual options volume on the call side or chasing put sweeps, Personalis Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.